Cardiovascular DiseasesMyocardial InfarctionRisk FactorsPlatelet Aggregation InhibitorsCoronary Artery DiseaseFollow-Up StudiesTiclopidineProspective StudiesAcute Coronary SyndromePredictive Value of TestsAngioplasty, Balloon, CoronaryTreatment OutcomeRisk AssessmentCoronary AngiographyKaplan-Meier EstimateBiological MarkersProportional Hazards ModelsStrokePrognosisTime FactorsPercutaneous Coronary InterventionPlatelet Function TestsStentsHydroxymethylglutaryl-CoA Reductase InhibitorsCohort StudiesAspirinIncidenceC-Reactive ProteinDeathCoronary RestenosisThrombosisPlaque, AtheroscleroticCoronary DiseaseCardiovascular AgentsDrug-Eluting StentsChi-Square DistributionHypertensionRandomized Controlled Trials as TopicDeath, Sudden, CardiacPeripheral Vascular DiseasesCoronary StenosisAngina PectorisRetrospective StudiesMyocardial RevascularizationMultivariate AnalysisNatriuretic Peptide, BrainDouble-Blind MethodDiabetes Mellitus, Type 2Proton Pump InhibitorsSeverity of Illness IndexHeart FailureRecurrenceDiabetes ComplicationsRiskUltrasonography, InterventionalDrug Therapy, CombinationBlood PressureCoronary ThrombosisHemorrhageElectrocardiographyOdds RatioROC CurveRegistriesSurvival RateAngina, UnstableLogistic ModelsCoronary Artery BypassPlatelet AggregationMyocardial IschemiaDrug InteractionsCoronary VesselsSirolimusSurvival AnalysisComorbidityAntihypertensive AgentsHeptanoic AcidsPostoperative ComplicationsAtherosclerosisUnited StatesVentricular Function, LeftPravastatinDiabetic AngiopathiesKidney Failure, ChronicAnticholesteremic AgentsRenal Insufficiency, ChronicCholesterol, LDLRenal DialysisPyrrolesJapanCalcinosisFluorobenzenesBrachial ArteryPrimary PreventionSecondary PreventionHypolipidemic AgentsKidney DiseasesCarotid Artery DiseasesChlorthalidoneCarotid ArteriesDyslipidemias